Paul M Clement Selected Research

monomethylauristatin F

1/2020

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul M Clement Research Topics

Disease

18	Neoplasms (Cancer) 03/2024 - 03/2009
13	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 03/2009
9	Squamous Cell Carcinoma of Head and Neck 03/2024 - 05/2015
7	Glioma (Gliomas) 01/2023 - 11/2016
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 01/2020
5	Neoplasm Metastasis (Metastasis) 06/2022 - 06/2016
4	Astrocytoma (Pilocytic Astrocytoma) 03/2024 - 11/2016
4	Fatigue 01/2022 - 05/2015
3	Brain Neoplasms (Brain Tumor) 05/2023 - 03/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Stomatitis 10/2019 - 05/2015
2	Acne Vulgaris 10/2019 - 05/2015
2	Exanthema (Rash) 10/2019 - 05/2015
2	Carcinoma (Carcinomatosis) 12/2016 - 06/2016
1	Cachexia 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Neuroblastoma 01/2023
1	Paraganglioma (Paragangliomas) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Carcinogenesis 01/2022
1	Meningioma (Meningiomas) 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Hypersensitivity (Allergy) 01/2020
1	Necrosis 11/2019
1	Nausea 10/2019
1	Diarrhea 10/2019
1	Osteonecrosis (Kienbock's Disease) 04/2018
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2017

Drug/Important Bio-Agent (IBA)

13	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 03/2009
7	Lomustine (CCNU)FDA Link 10/2023 - 11/2017
7	Bevacizumab (Avastin)FDA Link 10/2023 - 03/2015
4	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2020
4	LigandsIBA 01/2022 - 12/2016
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2009
3	AfatinibIBA 10/2023 - 05/2015
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 06/2020
3	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2020
3	Peptide Receptors (Peptide Receptor)IBA 01/2022 - 01/2020
3	depatuxizumab mafodotinIBA 08/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 03/2024 - 10/2023
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2020
2	epidermal growth factor receptor VIIIIBA 01/2020 - 03/2009
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2015
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 12/2016
2	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 05/2015
2	PlatinumIBA 01/2019 - 05/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 12/2016
2	Ifosfamide FDA LinkGeneric 01/2017 - 06/2016
1	B7-H1 AntigenIBA 03/2024
1	AntibodiesIBA 03/2024
1	Programmed Cell Death 1 ReceptorIBA 10/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2023
1	Octreotide (Sandostatin)FDA LinkGeneric 06/2023
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 06/2023
1	AMG232IBA 05/2023
1	Complement System Proteins (Complement)IBA 05/2023
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023
1	AntigensIBA 01/2023
1	Peptides (Polypeptides)IBA 06/2022
1	Alkaline PhosphataseIBA 06/2022
1	Serum AlbuminIBA 06/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	TrabectedinIBA 01/2022
1	larotrectinibIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Edotreotide (SMT 487)IBA 01/2022
1	TropomyosinIBA 01/2022
1	EpitopesIBA 01/2020
1	NVP-BKM120IBA 01/2020
1	NucleotidesIBA 01/2020
1	monomethylauristatin FIBA 01/2020
1	Ga(III)-DOTATOCIBA 01/2020
1	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	durvalumabIBA 01/2019
1	Denosumab FDA Link 04/2018
1	Diphosphonates (Bisphosphonates)IBA 04/2018
1	Bone Density Conservation AgentsIBA 04/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 12/2016

Therapy/Procedure

11	Therapeutics 03/2024 - 05/2015
10	Radiotherapy 05/2023 - 05/2015
9	Drug Therapy (Chemotherapy) 01/2023 - 06/2016
2	Precision Medicine 01/2022 - 10/2019
2	Palliative Care (Palliative Therapy) 06/2016 - 01/2014
1	Immunotherapy 01/2023
1	Drug Tapering 01/2023
1	Conformal Radiotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Neoadjuvant Therapy 01/2017